Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
71 hedge funds and large institutions have $356M invested in Repare Therapeutics in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 11 closing their positions.
62,533% more call options, than puts
Call options by funds: $1.88M | Put options by funds: $3K
0% more funds holding
Funds holding: 71 → 71 (0)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
1.09% less ownership
Funds ownership: 79.36% → 78.27% (-1.1%)
12% less capital invested
Capital invested by funds: $403M → $356M (-$47.1M)
25% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
CHI Advisors
New York
|
+$5.45M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$5.41M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$2.41M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$2.41M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$24.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.4M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
-$4.49M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.9M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.48M |
RPTX Hedge Fund Activity: Q3 2022 in Review
71 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2022, worth a combined $356M — down 12% from $403M a quarter earlier.
Fund positioning in RPTX was balanced in Q3 2022: 11 funds opened new positions, 11 closed out, 18 added to existing stakes and 24 trimmed.
The largest buyer was CHI Advisors, adding an estimated $5.45M. The largest seller was T. Rowe Price Associates, cutting an estimated $24.7M.
- 71 institutional investors held Repare Therapeutics (RPTX) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $356M of Repare Therapeutics stock for Q3 2022, down 12% quarter-over-quarter.
- 11 funds opened new Repare Therapeutics positions in Q3 2022 and 11 closed out, a net change of 0 holders.
- The largest Repare Therapeutics buyer in Q3 2022 was CHI Advisors, an estimated $5.45M added.
- The largest Repare Therapeutics seller in Q3 2022 was T. Rowe Price Associates, an estimated $24.7M sold.
Based on aggregated 13F filings for Q3 2022.